Literature DB >> 15867346

SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation.

Fatima Banine1, Christopher Bartlett, Ranjaka Gunawardena, Christian Muchardt, Moshe Yaniv, Erik S Knudsen, Bernard E Weissman, Larry S Sherman.   

Abstract

Brahma (Brm) and brahma-related gene-1 (Brg1) are mammalian homologues of SWI/SNF chromatin-remodeling factor subunits that can regulate both transcriptional activation and repression. Both Brg1 and Brm are mutated or deleted in numerous cancer cell lines, leading to the altered expression of genes that influence cell proliferation and metastasis. Here, we find that the promoters of two such genes, CD44 and E-cadherin, are hypermethylated in cells that have lost Brg1 or Brm. In two carcinoma cell lines that lack functional Brg1 and Brm, CD44 and E-cadherin expression are induced by the demethylating agent 5-aza-2'-deoxycytidine. Transfection with either Brg1 or Brm also induces CD44 and E-cadherin transcription and protein expression in these cells, as well as loss of methylation at sequences in the promoters of both genes. Chromatin immunoprecipitation assays show that Brg1 and Brm associate with these regions of the CD44 and E-cadherin promoters, suggesting that SWI/SNF protein complexes may directly influence the loss of DNA methylation. In vivo, Brm-deficient mice also show methylation and silencing of the CD44 promoter. Collectively, these data implicate loss of SWI/SNF-mediated transcriptional activation as a novel mechanism to increase DNA methylation in cancer cells and provide insight into the mechanisms underlying aberrant gene induction and repression during tumor progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15867346     DOI: 10.1158/0008-5472.CAN-04-3554

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  55 in total

Review 1.  A decade of exploring the cancer epigenome - biological and translational implications.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

2.  Transcriptional coactivators are not required for herpes simplex virus type 1 immediate-early gene expression in vitro.

Authors:  Sebla B Kutluay; Sarah L DeVos; Jennifer E Klomp; Steven J Triezenberg
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

3.  p53 chromatin epigenetic domain organization and p53 transcription.

Authors:  Chia-Hsin Su; Yih-Jyh Shann; Ming-Ta Hsu
Journal:  Mol Cell Biol       Date:  2008-10-20       Impact factor: 4.272

Review 4.  Hijacking the chromatin remodeling machinery: impact of SWI/SNF perturbations in cancer.

Authors:  Bernard Weissman; Karen E Knudsen
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

5.  Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria.

Authors:  Scott R Plotkin; Jaishri O Blakeley; D Gareth Evans; C Oliver Hanemann; Theo J M Hulsebos; Kim Hunter-Schaedle; Ganjam V Kalpana; Bruce Korf; Ludwine Messiaen; Laura Papi; Nancy Ratner; Larry S Sherman; Miriam J Smith; Anat O Stemmer-Rachamimov; Jeremie Vitte; Marco Giovannini
Journal:  Am J Med Genet A       Date:  2013-02-07       Impact factor: 2.802

6.  Brg1 inhibits E-cadherin expression in lung epithelial cells and disrupts epithelial integrity.

Authors:  Ting Wang; Wenjing Zou; Chao Niu; Fengxia Ding; Yaping Wang; Shuang Cai; Hua Zhu; Daiyin Tian; Jihong Dai; Enmei Liu; Qing Lu; Zhou Fu; Lin Zou
Journal:  J Mol Med (Berl)       Date:  2017-08-11       Impact factor: 4.599

Review 7.  SWI/SNF chromatin remodeling complexes and cancer.

Authors:  Jaclyn A Biegel; Tracy M Busse; Bernard E Weissman
Journal:  Am J Med Genet C Semin Med Genet       Date:  2014-08-28       Impact factor: 3.908

Review 8.  Dysregulation of Hyaluronan Homeostasis During White Matter Injury.

Authors:  Taasin Srivastava; Larry S Sherman; Stephen A Back
Journal:  Neurochem Res       Date:  2019-09-21       Impact factor: 3.996

9.  SWI/SNF chromatin-remodeling factor Smarcd3/Baf60c controls epithelial-mesenchymal transition by inducing Wnt5a signaling.

Authors:  Nicole Vincent Jordan; Aleix Prat; Amy N Abell; Jon S Zawistowski; Noah Sciaky; Olga A Karginova; Bingying Zhou; Brian T Golitz; Charles M Perou; Gary L Johnson
Journal:  Mol Cell Biol       Date:  2013-05-28       Impact factor: 4.272

10.  Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitors.

Authors:  Elizabeth M Algar; Andrea Muscat; Vinod Dagar; Christian Rickert; C W Chow; Jaclyn A Biegel; Paul G Ekert; Richard Saffery; Jeff Craig; Ricky W Johnstone; David M Ashley
Journal:  PLoS One       Date:  2009-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.